A detailed history of Lathrop Investment Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lathrop Investment Management Corp holds 4,530 shares of BMY stock, worth $259,704. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,530
Holding current value
$259,704
% of portfolio
0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $179,659 - $234,427
4,530 New
4,530 $234,000
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $1,696 - $2,024
-35 Reduced 0.74%
4,697 $241,000
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $2,315 - $2,589
-40 Reduced 0.84%
4,732 $275,000
Q1 2023

Apr 20, 2023

SELL
$65.71 - $74.53 $6,570 - $7,453
-100 Reduced 2.05%
4,772 $331,000
Q4 2022

Jan 17, 2023

SELL
$68.48 - $81.09 $14,928 - $17,677
-218 Reduced 4.28%
4,872 $351,000
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $1 - $691
-9 Reduced 0.18%
5,090 $362,000
Q2 2022

Jul 21, 2022

BUY
$72.62 - $79.98 $16,702 - $18,395
230 Added 4.72%
5,099 $393,000
Q1 2022

Apr 19, 2022

BUY
$61.48 - $73.72 $64,000 - $76,742
1,041 Added 27.19%
4,869 $356,000
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $3,539 - $4,126
66 Added 1.75%
3,828 $239,000
Q3 2021

Oct 15, 2021

SELL
$59.17 - $69.31 $65,087 - $76,241
-1,100 Reduced 22.62%
3,762 $223,000
Q2 2021

Jul 21, 2021

SELL
$61.91 - $67.42 $1,857 - $2,022
-30 Reduced 0.61%
4,862 $325,000
Q1 2021

Apr 19, 2021

SELL
$59.34 - $66.74 $35,604 - $40,044
-600 Reduced 10.92%
4,892 $309,000
Q4 2020

Jan 26, 2021

BUY
$57.74 - $65.43 $17,841 - $20,217
309 Added 5.96%
5,492 $341,000
Q3 2020

Oct 19, 2020

SELL
$57.43 - $63.64 $3,905 - $4,327
-68 Reduced 1.29%
5,183 $312,000
Q2 2020

Jul 30, 2020

BUY
$54.82 - $64.09 $20,612 - $24,097
376 Added 7.71%
5,251 $309,000
Q1 2020

Apr 15, 2020

BUY
$46.4 - $67.43 $226,200 - $328,721
4,875 New
4,875 $272,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lathrop Investment Management Corp Portfolio

Follow Lathrop Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lathrop Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lathrop Investment Management Corp with notifications on news.